tirzepatide pyridoxine compound Compounded (GLP-1/GIP) COMPOUNDED TIRZEPATIDE

Both are effective for weight loss, but Mounjaro (tirzepatide) has shown slightly greater average weight reduction in clinical trials compared to Wegovy (semaglutide)

Although the literature point towards aversive responses to GLP-1, some studies have still found reductions in food reward-motivated behavior by brain site-specific GLP-1R agonists using doses that were not associated with CFA and/or pica

All staff is friendly

Safety Concerns, Contraindications, and Provider Guidance Dual GLP-1 therapy poses cumulative risks for severe nausea, vomiting, pancreatitis, and acute kidney injury

Well review your health history, weight loss goals, and determine if Semaglutide (GLP-1) or Tirzepatide (GLP-1/GLP-2) is the right option for you